Expressions of interest open to participate in MASLD lived experience focus group

LiverWELL is leading the development of a Policy Paper relating to metabolic dysfunction-associated steatotic liver disease (MASLD, also known as fatty liver disease),
in collaboration withour network of sector experts. The paper will aim to raise awareness and knowledge about MASLD amongst poliy makers and the healthcare sector and provide recommendations for action.

We are now seeking to engage people with lived experience of MASLD in a paid online focus group in January to make sure the paper and its key messages are shaped by people with lived experience of MASLD. You can submit your expression of interest to participate in this focus group by completing the online form linked below.